Key result
Elevated pregnancy HbA1c despite normal OGTT links to ~78% needing pharmacotherapy and postpartum dysglycemia.
Observational (n=1,090)
Answers are grounded in this paper and cite their sources.
We examined whether pregnant women with a normal glucose tolerance test (OGTT) by New Zealand (NZ) criteria, but elevated HbA1c are a clinically important group with gestational diabetes (GDM). Eighty women with a normal OGTT and HbA1c > 40 mmol/mol, compared with others with GDM, had a significantly higher BMI and were more likely Pacific. Pharmacotherapy was prescribed in 77.5%. Post-partum OGTT and HbA1c were abnormal in 9/43(20.9%) and 27/42(64.3%), respectively. In 1090 women being screened for GDM by OGTT, most women with GDM had an HbA1c ≤ 40 mmol/mol. In the 22.1% of women with an HbA1c > 40 mmol/mol, the OGTT was normal in 61.8%. For centres using HbA1c to screen for underlying prediabetes/diabetes, these data show that a result >40 mmol/mol identifies women who are likely to require pharmacotherapy. An OGTT is still recommended to diagnose GDM, but these data raise questions about a possible role for HbA1c in high risk women with a nondiagnostic OGTT.
No takes yet. Share an insight, caveat, or question.
Rowan et al. (2013) conducted an observational in Gestational diabetes (GDM) (n=1,090). Normal 75 g OGTT with elevated HbA1c (>40 mmol/mol) in pregnancy vs. Other women with gestational diabetes (or HbA1c ≤ 40 mmol/mol) was evaluated on Pharmacotherapy requirement in pregnancy and post-partum glucose abnormality. Elevated pregnancy HbA1c (>40 mmol/mol) despite a normal OGTT identified women frequently needing pharmacotherapy and having abnormal post-partum HbA1c and OGTT.
Synapse has enriched 10 related papers. Consider them for comparative context: